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Abstract
This paper will provide a brief history and description 
of the Cochlear Implant, including early research, 
development, experimentation, and implementation  of 
the implant plus the names of many of the most 
renowned developers and producers. 
Second: Adam Kissiah's involvement in hearing 
research subsequent to the experience of personal 
hearing loss onset in the Early 1970s, deriving design 
of basic specifications for simulation of the electronic 
functioning of the inner ear (Cochlea) in humans.  
Kissiah’s subsequent award of Patent (4,063,048, 
December 13, 1977) accomplished through the 
Kennedy Space Center’s Technology 
Commercialization Program and Patent Counsel, 
James O. Harrell, Esq.
Third: How our natural hearing mechanism works, 
and how the Cochlear implant works in the correction 
of hearing loss.                                                    
Fourth: Information regarding implant availability 
including manufacturers, costs, clinics, surgical 
aspects, and post-operative activation (therapy) 
considerations. 
Fifth:  Sources for additional information. 
1. Introduction 
It is the desire of this paper to provide you with 
some information that you will find interesting, and 
will perhaps answer some questions you may have 
about hearing in general and the cochlear implant 
specifically. I would be especially delighted if you 
learn something that could make a beneficial change in 
your life, or in the life of a family member or a friend.  
The cochlear implant has emerged over the last 
twenty five years, and especially in the last five years, 
as a most welcome instrument in life enhancement for 
many previously deaf and hard-of-hearing persons. It 
has done so by providing a means of hearing for the 
first time for many persons, and by restoring hearing 
from years past for many others; yet it remains a 
controversial subject for many, both in the deaf 
community, and to hearing persons as well.  
2. History of the Cochlear Implant 
The idea for artificial or electronic correction of 
hearing loss was first publicized in 1957 when the 
French team of Djourno and Eyries implanted a patient 
with a single electrode into the middle ear cavity near 
the auditory (8th cranial) nerve, and were able to 
transmit perceivable “noise” to the patient. This was 
very significant in that the patient was not harmed by 
the procedure and some sensation was transmitted to 
him, which in turn encouraged further experimentation 
and cochlear implant research.  
Beginning in the nineteen sixties, and enduring to 
this day, the most noted and recognized pioneer in 
basic hearing stimulation research in the USA is Dr. 
Wm. F. House of the House Ear Institute (HEI), 
located in Sylmar (Los Angeles), CA. (Cochlear 
Implants, My Perspective, Wm F. House, M.D.) 
Dr. House began experimental implantation of 
electrodes in humans in the early sixties. By 1969 he 
had inserted single and multi-electrode implants into 
several patients, and in 1971, he implanted his first 
“permanent” single-wire system. Dr House implanted a 
more advanced system in a patient in 1979. Also in the 
1970-1982 time period, HEI, in partnership with 
Minnesota Mining and Manufacturing (3M) Company, 
implanted five patients through a clinical trial project.  
In the 1990s Dr. House and HEI also participated in 
development of the ALL-HEAR single-electrode 
system. HEI has recently gained encouraging results in 
experiments with brain-stem implants where the 
acoustic nerve (eighth cranial) is inoperative. Also, 
good results have been obtained in hybrid implants, in 
which patients with good low–frequency hearing 
sensitivity, but extremely poor high–frequency 
response, can benefit. 
Dr. House and the House Ear Institute (HEI) are the 
forerunners of the current Advanced Bionics 
Corporation, one of the three major providers of 
cochlear implants today.  
The second person or group of note is the well-
known and highly praised Dr. Graeme Clarke of 
Sydney, and the University of Melbourne, Australia, 
forerunners of Cochlear Americas, Ltd. They are the 
second (of three) major manufacturers.  
Dr. Clark and colleagues also began their research 
program in the 1960s. He was highly supported by the 
Australian government, and his program was on par 
with Dr. William House and the USA research 
programs. In 1977, he published the results of a multi-
electrode implant. Another report in 1979 published by 
the Australian team described a multi-channel device 
that would eventually lead to their most popular 
implant, namely the Cochlear Americas’ “Nucleus”. 
Other well-known researchers during the time period 
beginning in the late seventies and early eighties 
included Dr. Blair Simmons and Dr. Robert White of 
Stanford University, who produced significant results 
in Cochlear implant development in their Stimuliss 
program and their Bioear program in association with 
Biostim, Inc.  There was also Drs. Michelson, 
Mersenich and Schindler of the University of San 
Francisco Medical Center, Dr. Claude Henri-Chouard 
of France, Dr. Donald Eddington of the University of 
Utah, principle researcher in development of the 
Inneraid implant, and Dr. Thomas Balkany, at the 
Denver Ear Institute, and later at the University of 
Miami and Jackson Memorial Hospital.  
It is noted that these early implants did not (yet) 
employ to the fullest extent the principles of synthesis 
of the audio spectrum and application of the place-
specific-audio components directly to specific 
locations of the acoustic nerve, as specified in patent 
4,063,048 (see below). As a result the patients sensed 
primarily background noises, and did not enjoy the full 
potential of the intelligence and communication factor 
of the spoken word, except as an aid to lip-reading. 
This new life-sense did, however, achieve the highly 
desirable quality of enabling deaf persons to emerge 
from the isolation of silence and enter the world of 
sound, which significantly improved their 
“attachment” to society.   
Still other notables of this era included Dr. Blake 
Wilson, Charles Finley and others at the Research 
Triangle Institute in Raleigh-Durham, NC, who 
pioneered in forming the Med-El Corporation, maker 
of the Pulsar CI-100. Med-El, Ltd is head-quartered in 
Innsbruck, Austria.  
Important research was also conducted (by others) 
at the University of Utah, the University of Oregon, 
and still others at the University of Toronto.  
Adam Kissiah of NASA-Kennedy Space Center 
(KSC) in Florida was also involved in his personal 
prosthesis design research during this time period.  
While employed with NASA-KSC, Kissiah, because of 
personal hearing problems, involved himself in a study 
of the general aspects of hearing. As a result, a design 
for the electronic simulation of the operation of the 
human cochlea (inner ear) was devised.  U.S. Patent 
was applied for through the Kennedy Space Center 
Technology Commercialization Program, James O. 
Harrell, Patent Counsel. Patent 4,063,048 was granted 
(issued) December 13, 1977, Reissue 31,031 on 
September 14, 1982. This was the first U.S. (world-
wide) Patent describing the basic design of the 
cochlear implant.  It was considered a breakthrough in 
design for providing artificial stimulation of the 
cochlea, providing realistic correction for hearing loss 
in humans.  
 More than 50 subsequent patent application 
referred to 4,063,048 as prior art in that field. This 
technology has therefore been available, and utilized 
since December, 1977. It is noteworthy and 
appropriate that member of the technical community 
should contribute the electronics design of the cochlear 
implant, and it is equally appropriate that the medical 
community should develop and produce the implant 
for the public. 
Below is a copy of the original (first page) Patent 
(4,063,048) which provides the basic specifications for 
all cochlear implants:      
Cochlear Implant Design – Patent 4,063,048 (12/1977) 
It is noted that the basic designs of Implants of today 
are unchanged from Patent 4,063,048 (Dec 13, 1977) 
except for ever evolving physical and performance 
improvements through modern developments in 
miniaturization, micro-circuitry, and both hardware 
and software applications designs. For comparison 
with modern design refer to the design of Dr. Phillip C. 
Loizou, Professor in the Engineering Department of 
The University of Texas at Dallas. See 
www.utdallas.edu/~loizou/cimplants/tutorial/loifig4.gif
3. The National Institutes of Health’s Role 
in Cochlear Ear Implant Development 
In the late seventies and early eighties and beyond,  
as a result of research by the leaders above, and 
technology breakthroughs (the Patent described), the 
National Institutes of Health (NIH) increased 
significantly its output of research money to university 
and other research centers. The NIH provided funding 
and guidance under the direction of Dr. F. Terry 
Hambrecht, director of the National Institutes for 
Neurological Diseases and Stroke (NINDS), and they 
also provided a central focus point for the cochlear 
implant’s development and production process.  
Contributions by private investors and donors also 
added significant funds in promoting a high level of 
research in all sectors of society in development of the 
cochlear implant.   
The above shows clearly that the National Institutes 
of Health and many persons and institutions 
contributed significantly to the development and 
production of the cochlear implant. 
4. The (Natural) Hearing Mechanism and 
How It Works 
The human hearing mechanism is a bio-engineering 
master-piece.  The external ear helps direct sound 
waves, or acoustic energy, to the eardrum, causing it to 
vibrate. These vibrations are transmitted through the 
ossicular chain of bones (maleus, incus, and stapes), 
through a small oval-shaped window into the inner ear 
(cochlea).  
Below: The Cochlear (Basilar) Membrane: From 
IEEE Engineering and Medicine and Biology, Volume 
6, Number 2, June, 1987 – Article Entitled “Coding of 
Acoustic Signals on the Auditory Nerve”, by G. Daniel 
Geisler, the University of Wisconsin-Madison. 
Figure 1: Schematic sketch of the cochlea, stretched 
out from its actual spiral form, catching a mid-
frequency traveling wave at a particular instant. 
Adapted from Zweig et al. IEEE copyright line (©
1987).
The cochlea is a bony cavity, shaped like a small 
snail shell, which is divided into two inner sections by 
a flexible membrane called the basilar, or cochlear, 
membrane. Vibrations, or sounds, entering the cochlea 
create waves, like sonar waves, in the fluid-filled 
cavity within the cochlea. This wave motion causes 
resonating vibrations at specific locations on the 
cochlear (basilar) membrane in accordance with the 
stimulating frequency(s). In normal hearing, some 
15,000 to 20,000+ delicate nerve endings, called hair 
cells, are attached on one end to the flexible cochlear 
membrane and the other to the acoustic (8th cranial) 
nerve.
The cochlear membrane extends the full internal 
length of the Cochlea. These mechano-electric nerves 
(hair cells that fire when agitated) generate electrical 
impulses in intelligent wave patterns in response to 
audio stimuli (waves), which are in turn transmitted to 
the hearing center of the brain by way of the auditory 
nerve. These wave patterns are recognized as “sound” 
which can contain “intelligence” which we label as 
voice, music, and many other classifications of audio 
information. 
In many deaf and hard of hearing persons these 
vital and delicate nerve endings that provide the link 
between the vibrating cochlear membrane and the 
acoustic nerve are missing. Reasons for the missing 
nerves range from physical trauma, inherited 
deficiencies, disease, ototoxic drugs, loud noises, and 
other causes. 
There are other physical abnormalities that result in 
“conductive” hearing loss in humans, such as 
otosclerosis (calcification), infection, scar tissue, fluid 
and wax build-up, etc. These losses are usually 
treatable locally by ear-nose and throat doctors.
As stated above, Patent 4,063,048 represents the 
first patented description of the basic specifications for 
the functioning of the human cochlea, and a means for 
correction for hearing loss from loss of “hair cells”.   
Because all implants share a common basic design, 
there is no clear-cut consensus that any one of the 
implants is superior to the others. All cochlear implant 
devices, however, display a wide range of 
enhancements, including physical designs and 
performance characteristics.  
Shown below is the Biostim Inc 
Implantable Hearing Stimulator I, (1980©)
Above is a pictorial display of an implantable 
hearing stimulator designed by Biostim, Inc., a 
biomedical instrumentation development company in 
1980.  Biostim, Inc., Lloyd A. Ferreira, President and 
Chief Executive Officer, was headquartered in 
Princeton, NJ, and working through contractual 
licensing agreement from Adam Kissiah, Jr., inventor 
of the design. In 1982 Biostim, Inc. through its 
subsidiary, Bioear, Inc. undertook a research program 
of the same name (Bioear) under an FDA approved 
experimental permit, an Investigational Device 
Exemption (IDE) in association with Stanford 
University, Dr. F. Blair Simmons, principal 
investigator and Dr. Robert White, Chairman of the 
Department of Electrical Engineering.    
....---
Biostim, Inc. Implantable Hearing Stimulator       
(1980©s)
5. How the Cochlear Implant Works 
Sound waves are picked up by a tiny microphone 
housed in a headpiece that is worn at ear level. The 
microphone output is routed to a processor, which 
synthesizes and rectifies the sounds into audio 
“spectral bands” with the aid of a number of band-pass 
filters. Envelope detectors convert the spectral bands 
into digital (pulsatile) signals.  
The digital impulses are shaped and controlled in 
amplitude, pulse-widths and application rates, etc. and 
routed to the primary windings of an electromagnetic 
transmitter. In some models, the microphone and 
transmitter are in the same piece, and in other models 
the microphone is in a behind-the-ear piece that looks 
like a standard hearing aid.
The transmitter, which is held by a magnet on the 
side of the head behind the ear, sends the pulsatile 
signals via magnetic induction, through the skin to the 
cochlea via receiver electrodes that have been inserted 
into the cochlea. These electrodes provide direct 
stimulation to the brain via the auditory nerve, sending 
impulses in intelligent wave patterns where they are 
interpreted as sounds.  
In recent years extensive (and very competitive) 
experimentation has been performed by all 
manufacturers in an effort to exploit all possible 
methods of synthesizing and applying the audio 
spectrum of electrical stimuli to the acoustic nerve, in a 
continual effort to achieve the maximum possible 
intelligence, fidelity and clarity of audio information. 
The preponderance of current usage is the outgrowth 
of the multi-channel design described in Patent 
4063048 (Dec, 1977)), although many experiments by 
the House Ear Institute in the single channel implant 
have achieved success in specialized applications.
Many new strategies for increasing the (effective) 
number of audio channels being applied to the acoustic 
nerve have been developed, thereby providing greater 
fidelity in a true reproduction of original audio inputs. 
These capabilities have resulted in dramatically 
increased so-called “open-set” comprehension scores 
for words and sentences in clinical trials and in true 
public environmental situations. All manufacturers 
make the greatest effort to ensure “backwards 
compatibility” of new applications, in order to make 
certain that new developments and modifications to 
implants are made available for upgrade to patients 
with older models of implants. This policy enables 
most cochlear implant users to be able to take 
advantage of the latest in implant technology. In some 
cases, older implants are replaced with new ones in 
order to receive these upgrades. Such terminology used 
by MED-EL as Continuous Interleaved Sampling 
(CIS), Virtual Channel Interleaved Sampling (VCIS), 
Compressed Analog (CA), are examples of the 
somewhat descriptive terminology of the several 
proprietary methods of the application of stimuli, both 
software and hardware oriented. These innovative 
methods have resulted in an accompanying dramatic 
increase in the effective number of channels of applied 
stimulus, and thus the intelligence conveyed. 
6. Selection Process for Candidates for the 
Cochlear Implant.
Infants and small children are placed in a special 
category.  More on this will be discussed in 6.1. 
The early childhood and adult candidate for an implant 
may obtain referral by a family physician or ear-nose-
and throat (ENT) physician to a known implanting 
physician, clinic or implant team; or the patient may 
make direct phone contact with an implant team/clinic 
(information provided herein).  Next, an appointment 
or interview will be scheduled. 
Candidates will be scheduled for an examination by 
a medical doctor and an audiologist for a detailed 
hearing examination.  A detailed psychological profile 
will also be established.  Some (not all)of the basic 
qualifications are:  Severe to profound hearing loss in 
both ears (70 db or greater); post-lingual onset of 
severe to profound hearing loss in adults; limited 
benefit from hearing aids; desire to improve hearing; 
realistic expectations;  no medical contraindications. 
At this point, approval to receive an implant will 
be recommended or denied.  If approved the candidate 
will be advised of costs, and your financial status will 
be determined.  You will be advised to seek approval 
of insurance coverage before advancing further into 
the program. 
It is important that the candidate make certain to 
inquire into the complete insurance coverage of all 
costs, including pre-surgical physicals, hearing 
examinations, psychological profiles, the surgery itself, 
plus the complete processor and all its parts and 
accessories. Make certain that the extensive post-
surgical audiological activation, programming 
(mapping) and speech therapy are included.  Prior 
written approval of insurance coverage before surgery 
will avoid costly surprises.  
Costs of the implant are thirty to sixty thousand 
dollars in the US but are gradually being reduced 
because of more efficient procedures and routines, 
insurance company pressures, and some competition 
from overseas.  
If approved, surgery will be scheduled and 
completed. Follow-up rehabilitation, plus extensive 
audiological training and therapy will be performed.  
The success rate for surgeries and electronics 
operability is 99 percent-plus. Success in 
understanding of the spoken word, and general 
usability of the implant is dependent on many factors, 
including the length of time of deafness, age, 
psychological factors, effort made to learn, and so on.  
Instantaneous achievement of full benefits of hearing 
and understanding is not to be expected.
The post-surgical audio programming is highly 
important. In many cases, maximum hearing benefit 
from the implant cannot be achieved without this 
formal and extensive programming (mapping), therapy 
and training. It can literally make the difference 
between success and failure to achieve maximum 
benefits from the implant. 
6.1 Early intervention 
Children and babies as young as 1 year old can 
receive cochlear implants. The U.S. Department of 
education makes a hearing loss brochure available 
entitled “Opening Doors: Technology and 
Communications Options for Children with Hearing 
Loss.”
The brochure is distributed by each state’s early 
intervention program and is on the U.S. Department of 
Education’s website at: 
www.ed.gov/about/offices/list/osers/products/opening
doors/.  The brochure provides information to help 
parents make important decisions about their 
children’s hearing health. 
Implanting of senior citizens - Dr. John Niparko of 
Johns-Hopkins University, in the Department of 
Otolaryngology, Head and Neck Surgery in Baltimore 
reported that in 2005, individuals over the age of 65 
accounted for 24% of cochlear implant surgeries (HLA 
Convention, 2006).  Medicare provides insurance 
coverage for patients who qualify.  Patients in their 
seventies, eighties, and even nineties have been 
successfully implanted. 
7. Some Commercial Implant Providers 
As stated above, because all implants share a 
common basic design, there is no clear-cut consensus 
that any one of the implants is superior to the others. 
Users of all three devices display a wide range of 
enhancements, physical designs and performance 
characteristics.
Advanced Bionics Inc. is a subsidiary of Boston 
Scientific, Inc., a company that is also a major 
manufacturer of heart pacemakers.  Advanced Bionics 
is an outgrowth of Dr. William F. House’ Hearing 
Research Center, now named the House Ear Institute 
(HEI). They were the makers of the older “Clarion” 
model implant, and they are also known as the maker 
of the “Bionic Ear” Hi-resolution (Hi-Res) system. 
Their latest models include the Hi-Res 90k implant and 
the Hi-Res “Auria”, with web sites at 
www.cochlearimplant.com, and www.bionicear.com.
Their offices are located in Sylmar, CA and France. 
The leader in the total number of Cochlear Implants 
made world-wide is the Australian Cochlear Americas, 
Ltd., headquartered in Sydney, Australia and maker of 
the Nucleus Freedom implant, with over 80,000 
persons implanted. Their web-site is 
www.cochlearamericas.com.
Med-El, Ltd.’s headquarters are in Innsbruck, 
Austria, with primary U.S. Offices in Raleigh-Durham, 
NC. Med-El makes the Combi 40+ implant and the 
New Pulsar CI-100 which includes their latest and 
most improved Med-El technology. Med-El’s website 
is www.medel.com.
MXM Laboratories – Digisonic, Inc. 
www.mxmlab.com.
AllHear, Inc. Post Office Box 330 
Aurora, Oregon 97002 
(503) 266-6730 (voice) 
(503) 266-6418 (fax) 
AllHear@AllHear.com 
 Since all of these devices have a similar range of 
performances, other criteria are considered when 
choosing a cochlear implant, such as usability of 
external components, cosmetic factors, battery life- 
whether replaceable or rechargeable, versatility of 
internal and external components, customer service 
from the manufacturer, the implanting physician, 
audiologist and the quality of association (familiarity) 
of personnel with a particular device, and other 
physical concerns. Only you can decide which is best 
for you. 
8. Some Internet Information Sources 
Deafness Research Foundation www.drf.org is a
8201 Greensboro Drive, Suite  
8201 McLean, VA 22102   
Phone (703) 610-9025
Gallaudet University www.gallaudet.edu is the world's 
only university geared specifically to the needs of the 
deaf. The site includes links to other deaf schools in 
the United States. 
The National Association of the Deaf (NAD) 
http://www.nad.org/. The NAD advocates the civil 
rights of the deaf and hard-of-hearing in a variety of 
areas including education, employment, health care, 
social services and telecommunications. 
614 Thayer Avenue                                                 
Silver Spring, MD 20910-4500                              
Phone (301) 587-1791
The National Theater of the Deaf (NTD) 
http://www.NTD.org/ offers information about 
upcoming performances, workshops and classroom 
visits. 
Silent News.org http://www.silentnews.org is a 
magazine Website that offers deaf news, message 
boards, and classifieds. 
9. Additional Sources for Information 
Alexander Graham Bell Association for the Deaf and 
Hard of Hearing (A.G. Bell) 3417 Volta Place, NW  
Washington, DC 20007 
Voice: (800) Hear-Kid or (202) 337-5221
TTY: (202) 337-5221, Fax (202) 337-8314 
Email:info@agbell.org 
E-mail: info@agbell.org
Internet: www.agbell.org
The American Academy of Otolaryngology-Head and-
Neck Surgery (AAO-HNS) 
One Prince Street
Alexandria, VA 22314
Voice: (703) 836-4444
TTY: (703) 519-1585 
FAX: (703) 683-5100
E-mail: webmaster@entnet.org
Internet:  www.entnet.org
The Cochlear Implant Association, Inc.                          
5335 Wisconsin Avenue NW, Suite 440      
Washington, DC 20015-2034                               
Voice: (202) 895-2781                                            
TTY: (202) 895-2781                                             
FAX: (202) 895-2782                                                  
E-mail webmaster@entnet.org  
National Association of the Deaf
614 Thayer Avenue                                                 
Silver Spring, MD 20910-4500                              
Phone (301) 587-1791
http://www.nad.org
E-mail: nadinfo@nad.org
House Ear Institute (HEI) 
2100 West Third Street, Fifth Floor 
Los Angeles, CA 90057 
Voice: (213) 483-4431 
TTY: (213) 484-2642 
FAX: (213) 483-8789 
E-mail: webmaster@hei.org
Internet: www.hei.org
For additional information exchange and interaction 
with other implant patients, see the Internet: 
http://www.groups.yahoo.com/group/ci/
Also search Google keyword “Cochlear Implant”, or 
see website www.hearagain.org
10. Closing Statements 
It is recommended that anyone who has a question 
about his or her own hearing or the hearing of a loved 
one or someone you know, that you or that person 
should contact qualified and practicing professionals, 
or hearing clinic to be tested and screened.  The 
importance of being properly tested cannot be stressed 
enough, especially where infants and small children 
are concerned.  They should be tested as early in life as 
possible.  Elderly people should not automatically 
assume that they are too old, or that they could not 
qualify.  Medicare pays for implants to qualified 
patients and it costs very little to ask questions.     
Patients in their sixties, seventies, eighties, and even 
ninety years of age have been successfully provided 
with cochlear implants.
Each person is obligated to himself and his family to 
ask questions and obtain information needed to be 
fully informed regarding his hearing and this vital 
human sensory capability. 
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           
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
       
 
       
      
      
       
      
    
       
     
 
      
  
     
 
  
 
 
             
   
 
 
 
 
 
 
          
  
 
      
 
 
 
 
 
                  
         
    
        
           
         
          
           
     
       
 
              
           
              
           
 
        
          
        
    
 
          
           
            
          
   
 
              
 
 
 
 
 
                      
  
                  
                                                                  
                                                                      
      
  
  
 
        
   
   
   
   
   
  
  
 
           
  
   
   
   
    
 
    
          
   
   
   
    
 
      
   
    
  
 
 
    
     
   
   
